OncoMatch/Clinical Trials/NCT07635836
Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer
Is NCT07635836 recruiting? Yes, currently enrolling (Jul 2026). This NA trial studies non-drug interventions for gastric cancer (gc).
This study includes patients diagnosed with proximal gastric cancer (Siewert type II/III, cT1-3N0-1M0) across six tertiary hospitals, who underwent either double-tract reconstruction (DTR) or tubular gastric anastomosis (TGA). Participants were divided into two groups based on the surgical procedure. We conducted a comparative analysis of postoperative outcomes by evaluating electronic medical records, postoperative gastroscopy, 24-hour esophageal pH monitoring, and relevant rating scales.
Check if I qualifyExtracted eligibility criteria
Cancer type
Gastric Cancer
Performance status
ECOG 0–2(Ambulatory, capable of self-care)
Demographics
Lab requirements
Kidney function
no severe dysfunction of kidney
Liver function
no severe dysfunction of liver
Cardiac function
no severe dysfunction of heart
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07635836 currently recruiting?
Yes, this trial is currently recruiting patients.
Is there an age limit?
Yes. Patients must be 75 years or younger.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages